Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor subfamily 4 group A member 1 (NR4A1), also known as Nur77, TR3, and NGFI-B, is an orphan nuclear receptor that functions as a transcription factor and plays diverse roles in cellular physiology and pathology.
NR4A1 typically acts without identified physiological ligands and can bind DNA response elements either alone or with other family members to regulate gene expression. It also influences protein function through nongenomic mechanisms involving cytoplasmic signaling pathways such as CAP1/AC/PKA signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor subfamily 4 group A member 1 (NR4A1).